A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2025 amid foreign exchange ...

Reported side effects include "erectile dysfunction, anxiety, suicidal ideation, brain fog, depression, fatigue, insomnia, ...

Health-care companies ticked up as traders awaited earnings. Shares of Big Pharma company Merck ticked down ahead of its earnings. Summit Therapeutics shares rallied after its lung cancer drug ...

Eli Lilly is suing four telehealth companies that prescribe compounded versions of the pharmaceutical company's weight loss ...

According to the FDA, they have not received official approval, and no comprehensive safety data has been submitted for them.

Philip Morris International gave its earnings outlook a bump after sustained momentum for its popular Zyn pouch brand powered its profit and revenue higher in the first quarter. Warner shifted to a ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Hims, Keeps and other companies advertise topical finasteride with limited disclosures of side effects.

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) ...

Hims & Hers Health, Inc. (HIMS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want ...